Decreasing height, increasing arthritis risk evolutionarily advantageous for humans

July 3, 2017, Stanford University Medical Center
Credit: CC0 Public Domain

A single genetic change linked both to a reduction in human height and an increase in osteoarthritis risk might seem like it would quickly be kicked to the evolutionary curb. After all, how could it be an advantage to be both shorter and less mobile in the cutthroat competition for scarce resources and fickle mates? Darwin's finches would be appalled.

Now, researchers at the Stanford University School of Medicine and at Harvard University have shown that, despite its association with the painful joint disease, this genetic variant has been repeatedly favored as early humans migrated out of Africa and into colder northern climates. At least half of Europeans and Asians harbor the gene variant, which is relatively rare in African populations.

"Because it's been positively selected, this is present in billions of people," said David Kingsley, PhD, professor of developmental biology at Stanford. "So even though it only increases each person's risk by less than twofold, it's likely responsible for millions of cases of arthritis around the globe. This study highlights the intersection between evolution and medicine in really interesting ways, and could help researchers learn more about the molecular causes of arthritis."

A more compact body structure due to shorter bones could have helped our ancestors better withstand frostbite and reduce the risk of bone fracture from falling, the researchers speculate. These advantages in dealing with chilly temperatures and icy surfaces may have outweighed the threat of osteoarthritis, which usually occurs after prime reproductive age.

Cold may have selected for gene variant

"The gene we are studying shows strong signatures of positive selection in many human populations," said Kingsley, who is also a Howard Hughes Medical Institute investigator and a member of Stanford Bio-X. "It's possible that climbing around in cold environments was enough of a risk factor to select for a protective variant even if it brought along an increase likelihood of an age-related disease like arthritis, which typically doesn't develop until late in life."

A paper describing the research will be published online July 3 in Nature Genetics. Kingsley is the senior author. Harvard graduate student Jiaxue Cao and former Stanford postdoctoral scholars Terence Capellini, PhD, and Hao Chen, PhD, share lead authorship. Capellini is now an associate professor of at Harvard, and Chen is an associate clinical scientist at Genentech Inc.

The researchers were studying a gene called GDF5 that Kingsley's laboratory first linked to skeletal growth in the early 1990s. GDF5 is involved in bone growth and joint formation, and mutations in the coding portion of the gene have been shown to cause malformations in leg-bone structure in mice. In humans, GDF5 mutations are associated with shorter stature and joint problems; in particular, two nucleotide changes immediately upstream of the gene have been strongly associated with a 1.2- to 1.8-fold increase in the risk of osteoarthritis.

In the new study, the researchers were interested in learning more about how the DNA sequences surrounding GDF5 might affect the gene's expression. Often, these noncoding sequences contain key regulatory regions known as promoters and enhancers. Capellini, Chen and Cao were able to identify a previously unknown enhancer region they termed GROW1, which is several thousand nucleotides downstream of GDF5.

When the researchers analyzed the sequence of GROW1 in the 1,000 Genomes Project database, which collects and compares sequences from many human populations around the globe, they identified a single nucleotide change that is highly prevalent in Europeans and Asians but that rarely occurs in Africans. When they introduced this nucleotide change into laboratory mice, they found that it decreased the activity of GDF5 in the growth plates of the long bones of fetal mice.

A common thread

Further research showed that this nucleotide change has been repeatedly favored during human evolution. Modern humans migrated from Africa between 50,000 and 100,000 years ago. But they weren't the first to leave the continent. Neanderthals and Denisovans moved north into Europe and Asia about 600,000 years ago. Interestingly, the researchers found that the same GROW1 variant was found in the DNA of both ancient and modern humans in Europe and Asia.

However, there's a dark side to this stocky, hardy body type: The GDF5 variant that reduces bone length comes hand-in-hand with the two upstream nucleotide changes known to confer an increased risk for osteoarthritis.

"It's clear that the genetic machinery around a gene can have a dramatic impact on how it works," said Capellini. "The variant that decreases height is lowering the activity of GDF5 in the growth plates of the bone. Interestingly, the region that harbors this variant is closely linked to other mutations that affect GDF5 activity in the joints, increasing the risk of osteoarthritis in the knee and hip."

"The potential medical impact of the finding is very interesting because so many people are affected," said Kingsley. "This is an incredibly prevalent, and ancient, variant. Many people think of osteoarthritis as a kind of wear-and-tear disease, but there's clearly a genetic component at work here as well. Now we've shown that positive evolutionary selection has given rise to one of the most common height variants and arthritis risk factors known in ."

Explore further: Third genetic link to osteoarthritis discovered

More information: Ancient selection for derived alleles at a GDF5 enhancer influencing human growth and osteoarthritis risk, Nature Genetics (2017). DOI: 10.1038/ng.3911

Related Stories

Third genetic link to osteoarthritis discovered

August 25, 2011
Researchers have today revealed a new gene associated with osteoarthritis. This is only the third gene to be identified for this painful and debilitating disease that affects more than 40 per cent of people aged more than ...

Genetic variant of p53 gene linked to breast cancer risk in premenopausal African American women

February 27, 2017
Scientists at The Wistar Institute in collaboration with Roswell Park Cancer Institute found a significant association between a rare genetic variant of the p53 gene present in African American women and their risk of developing ...

Study identifies African-specific genomic variant associated with obesity

March 13, 2017
An international team of researchers has conducted the first study of its kind to look at the genomic underpinnings of obesity in continental Africans and African-Americans. They discovered that approximately 1 percent of ...

Recommended for you

Targeting the engine room of the cancer cell

June 18, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug ...

Scientists learn more about how gene linked to autism affects brain

June 18, 2018
New preclinical research shows a gene already linked to a subset of people with autism spectrum disorder is critical to healthy neuronal connections in the developing brain, and its loss can harm those connections to help ...

161 genetic factors for myopia identified

June 15, 2018
The international Consortium for Refractive Error and Myopia (CREAM) recently published the largest-ever genetic study of myopia in Nature Genetics. Researchers from the Gutenberg Health Study at the Medical Center of Johannes ...

Genetic disorder identified in children

June 15, 2018
A genetic defect affecting normal development in children has been identified by a study involving University of Queensland researcher and alumnus Professor David Coman.

Scientists discover biomarker for flu susceptibility

June 13, 2018
Researchers at the Stanford University School of Medicine have found a way to predict whether someone exposed to the flu virus is likely to become ill.

Brain secrets that flow in our blood

June 13, 2018
Our blood can be used to uncover genetic secrets inside the brain, according to University of Queensland research.


Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Jul 03, 2017
"In a study published online Nov. 6 in Nature Medicine, investigators at the Stanford University School of Medicine have shown that the development of osteoarthritis is in great part driven by low-grade inflammatory processes. This is at odds with the prevailing view attributing the condition to a lifetime of wear and tear on long-suffering joints.

""It's a paradigm change," said William Robinson, MD, PhD, the study's senior author..."

-Our immune systems have been forced to overperform due to millenia of close contact with domesticated animals and their diseases. And when there is no enemy to fight, like an idle standing army they will begin to prey on the body itself. Chronic inflammation is the root cause of many of our maladies.

1 / 5 (1) Jul 03, 2017
TGoO, you bring up an interesting compliment to the research in this article.

I think that the possible combinations of environmental and genetic diversity of ailments, leads me to opinionate that genetics is a. crapshoot.

The multitude of causations for biological afflictions have many contributions. And resolving one issue, one ecological challenge, will undoubtedly result in new, unexpected results.

As the saying goes, resolving a present problem, all too often causes two new problems you didn't expect. And often, resurrects an old problem, you had thought long gone. Like a zombie, rising from it's grave.

This is why the pseudo-science of Racial Eugenics has been such a failure. See breeding of race horses and the poor dumb fools who bet that the progeny can surpass the parentage.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.